Author Archive

A Legacy of Corruption in the FDA and Big Pharma

Written by The Mises Institute

Our healthcare system is broken, a fact nobody would have disputed in pre-Covid days. Regulatory capture is a reality, and the pharmaceutical industry is fraught with examples. Yet we trusted private-public partnerships to find an optimal solution to a global pandemic, assuming a crisis would bring out the best in historically corrupt institutions.

Continue Reading 5 Comments

Why the Biden COVID-19 Vaccine Mandate is Unconstitutional

Written by substack.com

On September 9, President Biden announced he would circumvent the democratic process, ordering the Secretary of the Department of Labor to require employers with over 100 workers to “ensure their workforces are fully vaccinated or show a negative test at least once a week.”

Continue Reading 5 Comments

John Kerry – Climate Doom Zealot

Written by Jack Dini

President Biden’s climate envoy John Kerry says that unless the word’s top 20 worst emitters do not take ‘bold action’ to tackle the climate crisis, the global environment will reach a point of no return. (1)

Continue Reading 7 Comments

How clinical trials are designed

Written by Pfizer Clinical Trials

Clinical trials help us learn more about ways to prevent or treat medical conditions. Research must show a study medicine is safe and effective before it can be approved for use.

Continue Reading 6 Comments

UK to COVID Jab Kids Despite Growing Proof It is Killing Children

Written by theexpose.uk

Authorities in the United Kingdom are so desperate to vaccinate children that they decided to disregard the decision made by the Joint Committee on Vaccination and Immunisation to not recommend children are given the jab and tasked the Chief Medical Officer Chris Whitty with making the decision instead, and he has now decided that the experimental treatment should be rolled out to children with immediate effect.

Continue Reading 17 Comments

Analysis of Effects of COVID Mask Mandates on Hospital Resources

Written by nih.gov

Coronavirus disease 2019 (COVID-19) threatens vulnerable patient populations, resulting in immense pressures at the local, regional, national, and international levels to contain the virus. Laboratory-based studies demonstrate that masks may offer benefit in reducing the spread of droplet-based illnesses, but few data are available to assess mask effects via executive order on a population basis.

Continue Reading 4 Comments